Pinnacle Associates’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-12,868
Closed -$268K 828
2023
Q2
$268K Buy
12,868
+3,213
+33% +$69.8K ﹤0.01% 703
2023
Q1
$227K Sell
9,655
-789
-8% -$21.2K ﹤0.01% 695
2022
Q4
$292K Sell
10,444
-3,086
-23% -$78.9K 0.01% 618
2022
Q3
$317K Buy
13,530
+728
+6% +$22K 0.01% 582
2022
Q2
$432K Sell
12,802
-1,734
-12% -$60.7K 0.01% 543
2022
Q1
$508K Sell
14,536
-1,731
-11% -$59.2K 0.01% 557
2021
Q4
$495K Sell
16,267
-11,396
-41% -$371K 0.01% 559
2021
Q3
$907K Sell
27,663
-14,252
-34% -$456K 0.02% 457
2021
Q2
$1.27M Buy
+41,915
New +$1.38M 0.02% 398

Other funds holding OGN

Pinnacle Associates's OGN Position: Q3 2023 in Review

Pinnacle Associates sold out of Organon & Co (OGN) in Q3 2023, closing a stake of 12,868 shares — an estimated $268K sold.

Pinnacle Associates first reported a position in OGN in Q2 2021 and held it in 9 quarters. The position peaked at $1.27M in Q2 2021. 730 funds tracked by Wall St. Rank hold OGN as of Q3 2023.

  • Pinnacle Associates reported no remaining Organon & Co position as of Q3 2023 after selling out during the quarter.
  • Pinnacle Associates sold 12,868 Organon & Co shares in Q3 2023, an estimated $268K.
  • Pinnacle Associates first reported a position in Organon & Co in Q2 2021 and held it in 9 quarters.
  • Pinnacle Associates's Organon & Co position peaked at $1.27M in Q2 2021.
  • 730 funds tracked by Wall St. Rank held Organon & Co as of Q3 2023.

Based on Pinnacle Associates's 13F filing for Q3 2023, filed 24 Oct 2023.